Inventor
HONGLIN LI
Inventor
CN
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds17%
Y02ATechnologies for adaptation to climate change17%
C07CAcyclic or carbocyclic compounds6%
C07HSugars6%
PatentTitleYear
12,180,146Antihypertensive polyol compound and derivative thereof202411,590,109Applications of novel thiazole derivative in treating virus infection202311,534,427Applications of novel thiazole derivative in treating inflammatory bowel diseases202211,464,795Saponin compound targeting PD-1 and application thereof202211,306,095Use of pteridinone derivative serving as EGFR inhibitor2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to UNIV EAST CHINA SCIENCE & TECH (4)· patent assignee history
2022Patents assigned to SHANGHAI INST MATERIA MEDICA CAS (1)· patent assignee history
2022Patents assigned to UNIV YUNNAN (1)· patent assignee history
2022–2024Based in CN· patent location history
2023Patents assigned to INST PASTEUR SHANGHAI CAS (1)· patent assignee history
2024Patents assigned to TAO PHARMACEUTICAL SUZHOU CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV EAST CHINA SCIENCE & TECH | 4 | 2022–2023 |
| INST PASTEUR SHANGHAI CAS | 1 | 2023 |
| SHANGHAI INST MATERIA MEDICA CAS | 1 | 2022 |
| TAO PHARMACEUTICAL SUZHOU CO LTD | 1 | 2024 |
| UNIV YUNNAN | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 5 | 2022–2024 |